Podchaser Logo
Home
113: After slow IPO, Gland Pharma finds more takers in secondary markets

113: After slow IPO, Gland Pharma finds more takers in secondary markets

Released Thursday, 26th November 2020
Good episode? Give it some love!
113: After slow IPO, Gland Pharma finds more takers in secondary markets

113: After slow IPO, Gland Pharma finds more takers in secondary markets

113: After slow IPO, Gland Pharma finds more takers in secondary markets

113: After slow IPO, Gland Pharma finds more takers in secondary markets

Thursday, 26th November 2020
Good episode? Give it some love!
Rate Episode

Whoever stuck their neck out in the Gland Pharma IPO is already sitting on decent gains. For an issue that offered full allotment for every application in the non-institutional category, it’s been among the best-performing IPOs for investors. Tune in here for more details.

Show More

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features